[go: up one dir, main page]

AU1582801A - Methods and compositions for protection against bovine herpesvirus - Google Patents

Methods and compositions for protection against bovine herpesvirus

Info

Publication number
AU1582801A
AU1582801A AU15828/01A AU1582801A AU1582801A AU 1582801 A AU1582801 A AU 1582801A AU 15828/01 A AU15828/01 A AU 15828/01A AU 1582801 A AU1582801 A AU 1582801A AU 1582801 A AU1582801 A AU 1582801A
Authority
AU
Australia
Prior art keywords
compositions
methods
protection against
bovine herpesvirus
against bovine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15828/01A
Inventor
Manjula Navaratnam
Subramaniam Srikumaran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nebraska System
Original Assignee
University of Nebraska Lincoln
University of Nebraska System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nebraska Lincoln, University of Nebraska System filed Critical University of Nebraska Lincoln
Publication of AU1582801A publication Critical patent/AU1582801A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6043—Heat shock proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU15828/01A 1999-11-05 2000-11-03 Methods and compositions for protection against bovine herpesvirus Abandoned AU1582801A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16372599P 1999-11-05 1999-11-05
US60163725 1999-11-05
PCT/US2000/030359 WO2001034184A2 (en) 1999-11-05 2000-11-03 Methods and compositions for protection against bovine herpesvirus 1

Publications (1)

Publication Number Publication Date
AU1582801A true AU1582801A (en) 2001-06-06

Family

ID=22591305

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15828/01A Abandoned AU1582801A (en) 1999-11-05 2000-11-03 Methods and compositions for protection against bovine herpesvirus

Country Status (2)

Country Link
AU (1) AU1582801A (en)
WO (1) WO2001034184A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5708601A (en) * 2000-04-17 2001-10-30 James E Rothman Javelinization of protein antigens to heat shock proteins
WO2002041921A2 (en) * 2000-11-03 2002-05-30 The Board Of Regents Of The University Of Nebraska Compositions for protection against bovine viral diseases
DK2318032T3 (en) 2008-06-26 2012-06-11 Orphazyme Aps Use of Hsp70 as a regulator of enzymatic activity
US9662375B2 (en) 2010-11-30 2017-05-30 Orphazyme Aps Methods for increasing intracellular activity of Hsp70
BRPI1101186B1 (en) * 2011-12-29 2019-06-25 Universidade Federal De Minas Gerais RECOMBINANT PROTEINS, POLYNUCLEOTES AND VACCINES AGAINST BOVINE HERPESVIRUS
CN107106494B (en) 2014-09-15 2021-12-21 奥菲泽米有限公司 Arilomo formulations
US10898476B2 (en) 2016-04-13 2021-01-26 Orphazyme A/S Heat shock proteins and cholesterol homeostasis
HRP20210047T1 (en) 2016-04-29 2021-04-16 Orphazyme A/S, c/o COBIS A/S Arimoclomol for treating glucocerebrosidase associated disorders
KR20230128462A (en) 2020-11-19 2023-09-05 제브라 덴마크 에이/에스 Process for preparing arimoclomol citrate and intermediates thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151267A (en) * 1988-07-15 1992-09-29 University Of Saskatchewan Bovine herpesvirus type 1 polypeptides and vaccines
US6017540A (en) * 1997-02-07 2000-01-25 Fordham University Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes

Also Published As

Publication number Publication date
WO2001034184A3 (en) 2002-03-07
WO2001034184A2 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
AU5911600A (en) System and method for protecting shared system files
AUPQ419099A0 (en) Novel compositions and methods
AU1831597A (en) Methods and compositions for inhibiting hexokinase
AU2409800A (en) Protective coating and methods for making same
AU3901100A (en) Method and composition for waterproofing
AU2557800A (en) Preservative compounds and compositions
AU1802901A (en) Improvement in cathodic protection system
AU5326100A (en) Pharmaceutical compositions and methods for use
AU3913800A (en) Novel antioxidant formulations and methods for using them
AU5565099A (en) Pharmaceutical compositions and methods for use
AU5601300A (en) Method and compositions for treating and preventing retinal damage
AUPP968699A0 (en) Therapeutic compositions and method for their preparation
AU1029501A (en) Cleaning-in-place composition and method for using the same
AU2243797A (en) Methods and compositions for inhibiting hexokinase
AU3209000A (en) System and method for esd protection
AU6056500A (en) Process and composition for temporarily suppressing pain
AU7685798A (en) Compositions and methods for preventing adhesion
AU4677900A (en) System for uniformly interconnecting and cooling
AU1582801A (en) Methods and compositions for protection against bovine herpesvirus
AU7816000A (en) Pediculocidal and veterinary compositions
AU7474100A (en) Methods and compositions for reducing immune response
AU7450900A (en) Polishing composition and method
AU4809000A (en) Method and composition for waterproofing
AUPO982097A0 (en) Methods and compositions for use therein
AU4328700A (en) Pseudomycin antifungal compositions and methods for their use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase